Profile
EmergingTech Ventures is a venture capital firm based in Morocco, focused on supporting transformative founders in emerging markets. The firm was founded with a mission to empower visionary entrepreneurs. They have a team dedicated to backing founders who deeply understand their markets and have the vision to build sustainable ventures. With a strong presence in Francophone Africa, EmergingTech Ventures stands out by providing hands-on support and leveraging deep market insights.
EmergingTech Ventures invests in sectors such as AI, HealthTech, and AgriTech, among others, with a focus on emerging markets. They primarily target early to growth-stage companies, offering check sizes between $500K and $3M. The firm has a notable total AUM of $60M with Fund I fully deployed and Fund II actively deploying.
Notable investments include Spore.bio, a company revolutionizing synthetic biology; Docline, a digital healthcare platform; Unissey, providing advanced biometric authentication; and SOWIT, focused on precision agriculture. These investments reflect the firm's commitment to backing bold, transformative founders.
Industry
EmergingTech Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
African Tech Fund
|
Venture Capital (VC)
|
Biotechnology
Internet and Web Services
AI
HealthTech
AgriTech
|
Pre-seed
Seed
Series A
|
Africa
|
$1-5 m
|
—
|
September 2026
|
|
Fund I
|
Venture Capital (VC)
|
AgriTech
HealthTech
MedTech
AI
Software
Internet and Web Services
Healthcare Services
Fintech
E-commerce/Marketplace
Biotechnology
|
Seed
Pre-seed
Series A
|
Europe
Africa
|
$1-5 m
|
—
|
September 2026
|
|
Fund II
|
Venture Capital (VC)
|
AgriTech
HealthTech
MedTech
AI
Software
Internet and Web Services
Healthcare Services
Fintech
E-commerce/Marketplace
Biotechnology
|
Seed
Pre-seed
Series A
|
Europe
Africa
|
$1-5 m
|
—
|
September 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.